Targeted Transgenic Overexpression of Mitochondrial Thymidine Kinase (TK2) Alters Mitochondrial DNA (mtDNA) and Mitochondrial Polypeptide Abundance: Transgenic TK2, mtDNA, and Antiretrovirals

This publication has 53 references indexed in Scilit:

• 3′-Azido-3′-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria
  Biochemical Pharmacology, 2006
• Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol γ hypothesis
  AIDS, 2006
• A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine
  Annual Review of Genetics, 2005
• Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine
  Toxicology and Applied Pharmacology, 2004
• Molecular insights into NRTI inhibition and mitochondrial toxicity revealed from a structural model of the human mitochondrial DNA polymerase
  Mitochondrion, 2004
• Genetic damage detected in CD-1 mouse pups exposed perinatally to 3?-azido-3?-deoxythymidine and dideoxyinosine via maternal dosing, nursing, and direct gavage
  Environmental and Molecular Mutagenesis, 2004
• Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy
  Progress in Cardiovascular Diseases, 2003
• Differential Incorporation and Removal of Antiviral Deoxynucleotides by Human DNA Polymerase γ
  Journal of Biological Chemistry, 2001
• Efficient Incorporation of Anti-HIV Deoxynucleotides by Recombinant Yeast Mitochondrial DNA Polymerase
  Published by Elsevier ,1995
• Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
  New England Journal of Medicine, 1990